Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health Innovation, Macquarie University, and University of Melbourne (Honorary Level C). She has a PhD in Advanced Behavioural Neuroscience from the School of Psychology, Monash University and a recently completed a NHMRC fellowship in Genomic Medicine at MCRI.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health...
Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health Innovation, Macquarie University, and University of Melbourne (Honorary Level C). She has a PhD in Advanced Behavioural Neuroscience from the School of Psychology, Monash University and a recently completed a NHMRC fellowship in Genomic Medicine at MCRI.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
Top Publications
Kraan, CM, Hocking, DR, Georgiou-Karistianis, N, Metcalfe, SA, Archibald, AD, Fielding, J, Trollor, J, Bradshaw, JL, Cohen, J, Cornish, KM.
Age and CGG-repeat length are associated with neuromotor impairments in at-risk females with the FMR1 premutation..
Neurobiol Aging
35(9)
:
2179.e7 -2179.13
2014
view publication
Kraan, CM, Hocking, DR, Bradshaw, JL, Georgiou-Karistianis, N, Metcalfe, SA, Archibald, AD, Fielding, J, Trollor, J, Cohen, J, Cornish, KM.
Symbolic sequence learning is associated with cognitive-affective profiles in female FMR1 premutation carriers..
Genes Brain Behav
13(4)
:
385 -393
2014
view publication
Shelton, AL, Cornish, K, Kraan, C, Georgiou-Karistianis, N, Metcalfe, SA, Bradshaw, JL, Hocking, DR, Archibald, AD, Cohen, J, Trollor, JN, et al.
Exploring inhibitory deficits in female premutation carriers of fragile X syndrome: through eye movements..
Brain Cogn
85:
201 -208
2014
view publication
Kraan, CM, Hocking, DR, Georgiou-Karistianis, N, Metcalfe, SA, Archibald, AD, Fielding, J, Trollor, J, Bradshaw, JL, Cohen, J, Cornish, KM.
Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers..
Am J Med Genet B Neuropsychiatr Genet
165B(1)
:
41 -51
2014
view publication
Grigsby, J, Cornish, K, Hocking, D, Kraan, C, Olichney, JM, Rivera, SM, Schneider, A, Sherman, S, Wang, JY, Yang, J-C.
The cognitive neuropsychological phenotype of carriers of the FMR1 premutation..
J Neurodev Disord
6(1)
:
28
2014
view publication